ProPhase Labs
OTC: PRPHUniondale, US · Delaware corporation · 46 employees on LinkedIn
ProPhase Labs is a biotech, genomics and consumer products company that provides whole genome sequencing services and develops diagnostics and therapeutics, including an early-detection test for esophageal cancer and novel cancer therapeutics. It also develops, manufactures, and commercializes health and wellness products.
Founders & leadership
TK
Ted KarkusExecutive
RV
Robert V. Cuddihy, Jr.Executive
Board
CA
CAROLINA ABENANTEBoard director
WH
WARREN HIRSCHBoard director
LG
LOUIS GECKELBoard director
LG
Louis GleckelBoard director
JM
James McCubbinBoard director
MB
Mark BurnettBoard director
JB
Jason BarrBoard director
ML
Mark LeventhalBoard director
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 3 rounds · 2015–2025
▶$3MraisedAug 2025 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedAug 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LOUIS GECKELDirector
- WARREN HIRSCHDirector
- CAROLINA ABENANTEDirector
- TED KARKUSExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $3M
- Minimum investment
- $500K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedJul 2025 · 2 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CAROLINA ABENANTEDirector
- WARREN HIRSCHDirector
- LOUIS GECKELDirector
- TED KARKUSExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $500K
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedDec 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedDec 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Louis GleckelDirector
- Robert V. Cuddihy, Jr.Executive Officer
- James McCubbinDirector
- Mark BurnettDirector
- Jason BarrDirector
- Mark LeventhalDirector
- Ted KarkusExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp37 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
IQVIA32 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Robinhood24 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with ProPhase Labs for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ProPhase Labs do?
- ProPhase Labs is a biotech, genomics and consumer products company that provides whole genome sequencing services and develops diagnostics and therapeutics, including an early-detection test for esophageal cancer and novel cancer therapeutics. It also develops, manufactures, and commercializes health and wellness products.
- How much funding has ProPhase Labs raised?
- ProPhase Labs has disclosed $5.5M raised across 3 rounds.
- Where is ProPhase Labs headquartered?
- ProPhase Labs is headquartered in Uniondale, US.